Effect of adjuvant trastuzumab treatment in conventional clinical setting: an observational retrospective multicenter Italian study

Clinical trials have shown the efficacy of trastuzumab-based adjuvant therapy in HER2-positive breast cancers, but routine clinical use awaits evaluation of compliance, safety, and effectiveness. Adjuvant trastuzumab-based therapy in routine clinical use was evaluated in the retrospective study GHEA...

Descripción completa

Detalles Bibliográficos
Autores principales: Campiglio, M., Bufalino, R., Sasso, M., Ferri, E., Casalini, P., Adamo, V., Fabi, A., Aiello, R., Riccardi, F., Valle, E., Scotti, V., Tabaro, G., Giuffrida, D., Tarenzi, E., Bologna, A., Mustacchi, G., Bianchi, F., Balsari, A., Ménard, S., Tagliabue, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758836/
https://www.ncbi.nlm.nih.gov/pubmed/23942848
http://dx.doi.org/10.1007/s10549-013-2658-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3758836/
https://www.ncbi.nlm.nih.gov/pubmed/23942848
http://dx.doi.org/10.1007/s10549-013-2658-z

Ejemplares similares